Characterization of hepatitis C virus resistance to grazoprevir reveals complex patterns of mutations following on-treatment breakthrough that are not observed at relapse
David Bonsall,1 Stuart Black,2 Anita YM Howe,2 Robert Chase,2 Paul Ingravallo,2 Irene Pak,2 Anthony Brown,1 David A Smith,1 Rory Bowden,1 Eleanor Barnes1 On behalf of the STOP HCV Consortium 1Translational Gastroenterology Unit, University of Oxford, Oxford, UK; 2Department of Infectious Diseases, M...
Main Authors: | Bonsall D, Black S, Howe AYM, Chase R, Ingravallo P, Pak I, Brown A, Smith DA, Bowden R, Barnes E |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-08-01
|
Series: | Infection and Drug Resistance |
Subjects: | |
Online Access: | https://www.dovepress.com/characterization-of-hepatitis-c-virus-resistance-to-grazoprevir-reveal-peer-reviewed-article-IDR |
Similar Items
-
Grazoprevir/elbasvir for the treatment of adults with chronic hepatitis C: a short review on the clinical evidence and place in therapy
by: Sulejmani N, et al.
Published: (2018-05-01) -
Elbasvir/grazoprevir in women with hepatitis C virus infection taking oral contraceptives or hormone replacement therapy
by: Hézode C, et al.
Published: (2019-11-01) -
Functional analysis of hepatitis C virus non-structural protein (NS) 3 protease and viral cofactor NS4A
by: Martin, Morgan Mackensie
Published: (2008) -
Functional analysis of hepatitis C virus non-structural protein (NS) 3 protease and viral cofactor NS4A
by: Martin, Morgan Mackensie
Published: (2008) -
Functional analysis of hepatitis C virus non-structural protein (NS) 3 protease and viral cofactor NS4A
by: Martin, Morgan Mackensie
Published: (2008)